NASDAQ (USD): Y-mAbs Therapeutics, Inc. (YMAB)
Last Price
11.59
Today's Change
-1.59 (12.06%)
Day's Change
11.50 - 12.96
Trading Volume
383,710
You are setting up a price and signal alert with 15 minutes delay. Click here to enjoy real-time price and signal alerts.
T4Q
31-Mar-2021
2020
2019
2018
2017
Revenue
238
1000
110
900
600
12
MQ Chat
Send individual or group chats with anyone on i3investor
MQ Trader
Earn MQ Points while trading with MQ Trader
MQ Affiliate
Earn side income from Affiliate Program
MQdemy
Online learning and teaching marketplace
1
CEO Morning Brief
Trump in Phone Call Advised Putin Not to Escalate in Ukraine — Washington Post
2
US Ordered TSMC to Halt Shipments of Chips for AI to China — Reuters
3
Dogecoin Outperforms Bitcoin as Trump Spurs Crypto Speculation
4
Hedge Funds Shorting Tesla Just Lost More Than US$5 Bil
5
Trump Seeks Fast Appointments; Elon Musk Makes Endorsement for Senate Leadership
#
Stock
Score
MSTR
MicroStrategy Incorporated
AGN
833
BABA
Alibaba Group Holding Limited
666
KXIN
Kaixin Auto Holdings
BITF
Bitfarms Ltd.
6
AAPL
Apple Inc.
500
7
PLTR
Palantir Technologies Inc.
466
8
CHMT
333
9
UEIC
Universal Electronics Inc.
10
NOC
Northrop Grumman Corporation
Last
Change
Volume
ELAB
0.026
+0.002
1,737,574,519
SLNA
0.03
-0.008
379,091,456
CYXT
0.065
0.00
369,807,727
XTIA
0.057
357,249,033
MTEM
0.61
+0.288
328,379,946
UWT
0.164
-0.002
244,137,454
SVMH
0.028
+0.004
242,669,307
QUBT
4.40
+1.74
229,041,399
AGIL
0.197
+0.114
206,404,986
LYLT
0.218
204,480,452
BRK-A
702,995.04
+745.00
1,402
NVR
9,190.00
+84.33
14,625
RTLA
209.90
+74.87
0
MKL
1,714.08
+58.72
66,959
WSO-B
518.97
+48.07
222
DDS
433.84
+45.33
224,377
BH-A
1,055.00
+38.00
1,044
ACSG
33.28
+33.28
99,050
EMSA
140.77
+30.77
EMLB
80.80
+30.30
MELI
1,774.05
-343.25
2,940,447
MPWR
592.31
-168.99
175,940
1,309.00
-138.99
2,237,917
1,395.13
-102.30
318,280
LOWC
30.18
-92.412
1,236,074
TDG
1,273.29
-89.71
598,793
NOW
643.29
-87.83
5,025,012
NVDA
762.00
-84.71
85,558,284
MEDP
357.30
-79.88
1,004,401
MDB
236.06
-73.94
10,812,930
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....